---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-344787"
form_type: "8-K"
ticker: "RCEL"
cik: "0001762303"
company_name: "AVITA Medical, Inc."
filed_at: "2026-08-11T20:30:18+00:00"
generated_at: "2026-08-11T20:31:10.047118+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# AVITA Medical amends PermeaDerm agreements: higher revenue share, EU/UK/AU expansion option

## Summary
- $500,000 fee gives AVITA right of first offer/refusal to expand exclusive PermeaDerm distribution to EU, UK, Australia.
- Revenue share from PermeaDerm rises to 67% (sheet) and 80% (glove) from July 1, 2026; extra payments if gross margin >50% (sheet) or >35% (glove).
- Growth minimums set: $1.0M in 2026, then 20% annual growth to $2.0736M by 2030; prior minimums waived.
- Stedical can sell in certain U.S. markets; AVITA supplies at cost +10%. For OUS (Asia) sales, price $200/carton + 10% manufacturing fee up to 1,600 cartons.
- Milestone payments: AVITA pays $1M if total sales exceed $45M, and $1.5M if exceed $90M.

## SEC filing metadata
- accession: 0001193125-26-344787
- form_type: 8-K
- ticker: RCEL
- cik: 0001762303
- company_name: AVITA Medical, Inc.
- filed_at: 2026-08-11T20:30:18+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1762303/000119312526344787/0001193125-26-344787-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1762303/000119312526344787/rcel-20260805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-344787
- JSON: https://secwatch.observer/filing/0001193125-26-344787.json
- Plain text: https://secwatch.observer/filing/0001193125-26-344787.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.